Nebivolol Accord (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Accord, is a beta blocker presented as an oral tablet for oral use. It selectively lowers elevated blood pressure and is indicated for adult patients with hypertension. The drug works by blocking β1‑adrenergic receptors while promoting nitric‑oxide mediated vasodilation, which reduces cardiac output and peripheral resistance.

GNH USA supplies Nebivolol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows GMP standards, provides batch‑tested products, and ensures reliable global logistics.

Nebivolol is a selective β1‑adrenergic receptor antagonist used in the management of hypertension, helping to achieve target blood pressure levels.

- Hypertension: reduces systolic and diastolic blood pressure in adult patients with high blood pressure.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: unusual tiredness or lack of energy. - Nasal congestion: blocked or runny nose. - Diarrhea: loose, frequent stools. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Bradycardia: abnormally slow heart rate. - Severe hypotension: marked drop in blood pressure leading to fainting. - Heart block: impaired electrical conduction in the heart. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy with Nebivolol, certain precautions should be considered.

- Blood pressure monitoring: check baseline and periodic readings. - Cardiac assessment: evaluate heart rate and rhythm, especially in patients with conduction disorders. - Asthma/COPD caution: use carefully in patients with reactive airway disease. - Gradual discontinuation: avoid abrupt stopping to prevent rebound hypertension. - Renal impairment adjustment: consider dose modification in severe kidney dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): increased risk of bradycardia and AV block. - Anti‑arrhythmic agents (amiodarone): enhanced negative chronotropic effect.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms. - NSAIDs: can reduce antihypertensive efficacy. - ACE inhibitors or ARBs: monitor for excessive blood pressure lowering.